ロード中...
Therapeutic potential of targeting IL-17 and IL-23 in sepsis
Severe sepsis is a major concern of public health in industrialized countries. It is estimated that in the United States 200,000-400,000 cases occur annually and resulting in an extensive burden for the health care systems. To date, no FDA-approved pharmacologic agents for the treatment or preventio...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3552565/ https://ncbi.nlm.nih.gov/pubmed/23369364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2001-1326-1-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|